NBIX ▼ -1.2% - Neurocrine Biosciences, Inc. Another Prader Willi patient prescribed Neurocrine's $NBIX Vykat has died, according to the FDA's AEMS database. That's the eighth patient death reported since the drug was approved. Like the other cases, "swelling" and hyperglycemia were listed as contributing factors. ADAM F STAT NEWS 02-NOV-2026 10:21 AM ET